edged

A Double-Edged Sword: New Hunter Syndrome Drug Offers Hope, But Age Restrictions Spark Urgent Calls for Equitable Access

The recent Food and Drug Administration (FDA) approval of Avlayah (tividenofusp alfa-eknm) for Hunter syndrome marks a significant advancement in…